Abbott (ABT) Tops Q4 EPS by 1c, Offers FY18 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq on track for record closing highs as focus turns to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Abbott Labs (ABT) PT Raised to $68 at Leerink Partners
January 25, 2018 7:16 AM ESTLeerink Partners raised its price target on Abbott Labs (NYSE: ABT) to $68.00 (from $60.00) while maintaining a Outperform rating.
... MoreAbbott Labs (ABT) PT Raised to $71 at Stifel
January 24, 2018 4:42 PM ESTStifel raised its price target on Abbott Labs (NYSE: ABT) to $71.00 (from $63.00) while maintaining a Buy rating following strong Q4 results.
Analyst Rick Wise said the company has significant and sustainable momentum heading into 2018.
... MoreAbbott Labs (ABT) PT Raised to $67 at Evercore ISI
January 24, 2018 12:34 PM ESTEvercore ISI raised its price target on Abbott Labs (NYSE: ABT) to $67.00 (from $64.00) while maintaining a Outperform rating.
The firm raised FY2018 EPS from $2.82 to $2.87, trimmed FY 2019 from $3.23 to $3.22 and raised FY 2020 from $3.55 to $3.56.
... More


